Clinical development is a vital part of our mission to provide innovative medicines that help people live better lives.
Our approach to development is twofold. First, we continue to actively explore the full potential of our current portfolio of medicines. Second, we look to strategically acquire development-stage medicines in Phase 1, 2 and 3. These clinical development opportunities include both company-sponsored and investigator-initiated studies.
We are currently involved in a number of studies within the United States. Full details may be found on clinicaltrials.gov.